Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome

Conditions

• Autoimmune Hepatitis
• Liver Abscess
• Non-Alcoholic Fatty Liver Disease
• Primary Biliary Cirrhosis
• Primary Sclerosing Cholangitis

Eligibility Criteria

Sex

ALL

Age

19 Years - N/A

Healthy Volunteers

Accepted

Study Details

In this study, we aim to identify gut microbiomes specific to patients with chronic refractory liver disease and to conduct a gut-liver axis study on the pathogenesis and disease progression.

Key Dates

First listed

Jul 25, 2024

Start date

Jul 8, 2024

Status verified

Mar 2026

Primary completion

Jul 8, 2029

Completion

Jul 8, 2029

Study Design

Enrollment

3,000 participants (estimated)

Primary Outcome Measure

Chi-square test [ Time Frame: Before treatment, 3~12months after treatment ]

Central Contacts

• Soon Ok Kim
  82-42-280-6717
  [email protected]
• Hyuksoo Eun
  82-42-280-7418
  [email protected]

Related Studies

• Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
  Recruiting · Sanford Health · Sioux Falls, South Dakota
• Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
  PHASE1 · Recruiting · Sacramento Pediatric Gastroenterology · Sacramento, California
• MRI Based Biomarkers in Pediatric Autoimmune Liver Disease
  Recruiting · Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio
• MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease
  Recruiting · Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio